ArticleJournal of translational medicine2024

Insights into gemcitabine resistance in pancreatic cancer: association with metabolic reprogramming and TP53 pathogenicity in patient derived xenografts.

Mariam M Konaté et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.